CC(C)C[C@@H](C(=O)O)n1cc(-c2cc(C(=O)N3CCNCC3)cc(-c3cn([C@@H](CCC(=O)O)C(=O)O)nn3)c2)nn1.Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?